JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, NOVEMBER 9, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.6629?guestAccessKey=8a2991f1-879b-45ec-a9f4-c35fd7e9bcbd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110920
What The Study Did: Researchers compared the effect and reach of studies about therapies for COVID-19 posted on the medRxiv preprint server, subsequent publications in medical journals of some of these studies, and journal articles that were not posted on either medRxiv or another preprint server.
Authors: Neil W. Schluger, M.D., of the New York Medical College, in Valhalla, New York, is the corresponding author.
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.